查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1701872

循环肿瘤细胞市场报告（按技术、应用、产品、样本、最终用户和地区）2025-2033

Circulating Tumor Cells Market Report by Technology, Application, Product, Specimen, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球循环肿瘤细胞 (CTC) 市场规模达 129 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 278 亿美元，2025-2033 年期间的成长率 (CAGR) 为 8.46%。由于生活方式的改变，遗传性疾病的盛行率不断上升，推动了市场的发展。

循环肿瘤细胞 (CTC) 是从原发性肿瘤中分离出来的癌细胞，以单一单位或簇的形式出现在循环系统中。它们具有不同的生物学表型，例如上皮、间质和混合上皮-间质。患者血液中的 CTC 水平可以早期发现癌症并作为预后指标。由于数量极少，因此使用多种技术来分离、富集和检测 CTC，例如免疫捕获、基于尺寸的分离、基于密度的分离和显微镜检查。它在液体活检、癌症研究、药物开发和临床生物标记方面也有广泛的应用。

循环肿瘤细胞（CTC）市场趋势：

由于遗传疾病导致的癌症盛行率不断上升、酒精消费量不断增加以及生活方式的快速变化是推动市场成长的关键因素。 CTC有助于肺癌、乳腺癌、消化道癌和前列腺癌的早期识别和即时监测。与此一致，CTC 在患者转移筛检和新型抗癌药物临床前研究的应用日益增多，有利于市场成长。此外，对微创（MI）诊断程序的需求不断增长，以及基于 CTC 的液体活检的广泛采用以实现快速恢復和限制创伤，为市场成长提供了相当大的推动力。除此之外，引入奈米技术来提高 CTC 分离和检测的灵敏度和效率，为市场成长提供了动力。此外，在医学研究中越来越多地利用细胞培养模型来开发药物筛选、疾病建模、基因组编辑和肿瘤免疫，为市场创造了积极的前景。此外，医疗保健专业人员和患者对早期癌症诊断重要性的认识不断提高，这对市场成长产生了积极影响。其他因素，包括生物医学影像和生物工程技术的快速进步、广泛的研究和开发 (R&D) 活动以及对预防医学和伴随诊断的不断增长的需求，预计将推动市场成长。

本报告回答的关键问题

  • 2024 年全球循环肿瘤细胞 (CTC) 市场规模？ 2025 年至 2033 年期间全球循环肿瘤细胞 (CTC) 市场的预期成长率为何？
  • 推动全球循环肿瘤细胞 (CTC) 市场发展的关键因素有哪些？
  • COVID-19 对全球循环肿瘤细胞 (CTC) 市场有何影响？
  • 基于技术，全球循环肿瘤细胞（CTC）市场如何分布？
  • 根据应用，全球循环肿瘤细胞 (CTC) 市场如何分布？
  • 根据产品，全球循环肿瘤细胞 (CTC) 市场如何分布？
  • 根据样本，全球循环肿瘤细胞 (CTC) 市场如何分布？
  • 全球循环肿瘤细胞（CTC）市场的主要区域有哪些？
  • 全球循环肿瘤细胞 (CTC) 市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球循环肿瘤细胞（CTC）市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依技术

  • CTC检测和富集方法
  • CTC直接检测方法
  • CTC分析

第七章：市场区隔：依应用

  • 临床/液体活检
    • 关键部分
      • 风险评估
      • 筛检和监测
  • 研究
    • 关键部分
      • 癌症干细胞与肿瘤发生研究
      • 药物/疗法开发

第八章：市场区隔：依产品

  • 试剂盒和试剂
  • 采血管
  • 设备或系统

第九章：市场区隔：依样本

  • 血
  • 骨髓
  • 其他体液

第十章：市场区隔：依最终用户

  • 医院和诊所
  • 研究与学术机构
  • 诊断中心

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第 16 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • BioFluidica Inc
    • Creatv MicroTech Inc.
    • CytoLumina Technologies Corp.
    • Fluxion Biosciences Inc.
    • Greiner Bio-One International GmbH
    • Ikonisys Inc
    • Menarini Silicon Biosystems
    • Miltenyi Biotec
    • Qiagen NV
    • Rarecells Diagnostics
    • Stemcell Technologies
Product Code: SR112025A6316

The global circulating tumor cells (CTC) market size reached USD 12.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 27.8 Billion by 2033, exhibiting a growth rate (CAGR) of 8.46% during 2025-2033. The rising prevalence of genetic disorders, owing to lifestyle changes, is propelling the market.

Circulating tumor cells (CTC) are cancer cells that split away from the primary tumor and appear in the circulatory system as singular units or clusters. They have different biological phenotypes, such as epithelial, mesenchymal, and mixed epithelial-mesenchymal. CTC levels in a patient's blood can allow early detection of cancer and act as a prognostic indicator. As they are in minimal quantity, several technologies are used for the isolation, enrichment, and detection of CTC, such as immunocapture, size-based separation, density-based separation, and microscopy. It also has wide-ranging applications in liquid biopsy, cancer research, drug development, and clinical biomarkers.

Circulating Tumor Cells (CTC) Market Trends:

The increasing prevalence of cancer due to genetic disorders, rising alcohol consumption, and rapid lifestyle changes are key factors driving the market growth. CTC assists in the early identification and real-time monitoring of lung, breast, digestive tract, and prostate cancer. In line with this, the increasing utilization of CTC in patient screening for metastasis and preclinical studies of new cancer drugs is favoring the market growth. Furthermore, the growing demand for minimally invasive (MI) diagnostic procedures and widespread adoption of CTC-based liquid biopsy to enable rapid recovery and limit trauma are providing a considerable boost to the market growth. Apart from this, the introduction of nanotechnology to improve the sensitivity and efficiency of CTC isolation and detection is providing an impetus to market growth. Moreover, increasing utilization in medical research to develop cell culture models for drug screening, disease modeling, genome editing, and tumor immunity is creating a positive outlook for the market. Additionally, the increasing awareness amongst healthcare professionals and patients about the importance of early cancer diagnosis is positively influencing the market growth. Other factors, including rapid advancements in biomedical imaging and bioengineering technology, extensive research and development (R&D) activities, and the rising demand for preventive medicine and companion diagnostics, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Technology:

  • CTC Detection and Enrichment Method
  • CTC Direct Detection Methods
  • CTC Analysis

Breakup by Application:

  • Clinical/Liquid Biopsy
  • Risk Assessment
  • Screening and Monitoring
  • Research
  • Cancer Stem Cell and Tumorigenesis Research
  • Drug/Therapy Development

Breakup by Product:

  • Kits and Reagents
  • Blood Collection Tubes
  • Devices and Systems

Breakup by Specimen:

  • Blood
  • Bone Marrow
  • Other Body Fluids

Breakup by End User:

  • Hospital and Clinics
  • Research and Academic Institutes
  • Diagnostic Centres

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnostics and Stemcell Technologies.

Key Questions Answered in This Report

  • 1.What was the size of the global Circulating Tumor Cells (CTC) market in 2024?
  • 2.What is the expected growth rate of the global Circulating Tumor Cells (CTC) market during 2025-2033?
  • 3.What are the key factors driving the global Circulating Tumor Cells (CTC) market?
  • 4.What has been the impact of COVID-19 on the global Circulating Tumor Cells (CTC) market?
  • 5.What is the breakup of the global circulating tumor cells (CTC) market based on technology?
  • 6.What is the breakup of the global Circulating Tumor Cells (CTC) market based on the application?
  • 7.What is the breakup of the global Circulating Tumor Cells (CTC) market based on the product?
  • 8. What is the breakup of the global Circulating Tumor Cells (CTC) market based on the specimen?
  • 9.What are the key regions in the global Circulating Tumor Cells (CTC) market?
  • 10.Who are the key players/companies in the global Circulating Tumor Cells (CTC) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Circulating Tumor Cells (CTC) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 CTC Detection and Enrichment Method
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 CTC Direct Detection Methods
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 CTC Analysis
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Clinical/Liquid Biopsy
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Risk Assessment
      • 7.1.2.2 Screening and Monitoring
    • 7.1.3 Market Forecast
  • 7.2 Research
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Cancer Stem Cell and Tumorigenesis Research
      • 7.2.2.2 Drug/Therapy Development
    • 7.2.3 Market Forecast

8 Market Breakup by Product

  • 8.1 Kits and Reagents
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Blood Collection Tubes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Devices or Systems
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Specimen

  • 9.1 Blood
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Bone Marrow
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Other Body Fluids
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospital and Clinics
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Research and Academic Institutes
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Diagnostic Centres
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 BioFluidica Inc
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Creatv MicroTech Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
    • 16.3.3 CytoLumina Technologies Corp.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Fluxion Biosciences Inc.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Greiner Bio-One International GmbH
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Ikonisys Inc
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Menarini Silicon Biosystems
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Miltenyi Biotec
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
    • 16.3.9 Qiagen N.V
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 Rarecells Diagnostics
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Stemcell Technologies
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio

List of Figures

  • Figure 1: Global: Circulating Tumor Cells Market: Major Drivers and Challenges
  • Figure 2: Global: Circulating Tumor Cells Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Circulating Tumor Cells Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Circulating Tumor Cells Market: Breakup by Technology (in %), 2024
  • Figure 5: Global: Circulating Tumor Cells Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Circulating Tumor Cells Market: Breakup by Product (in %), 2024
  • Figure 7: Global: Circulating Tumor Cells Market: Breakup by Specimen (in %), 2024
  • Figure 8: Global: Circulating Tumor Cells Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Circulating Tumor Cells Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Circulating Tumor Cells (CTC Detection and Enrichment Method) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Circulating Tumor Cells (CTC Direct Detection Methods) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Circulating Tumor Cells (CTC Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Circulating Tumor Cells (CTC Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Circulating Tumor Cells (Clinical/Liquid Biopsy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Circulating Tumor Cells (Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Circulating Tumor Cells (Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Circulating Tumor Cells (Kits and Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Circulating Tumor Cells (Kits and Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Circulating Tumor Cells (Blood Collection Tubes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Circulating Tumor Cells (Blood Collection Tubes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Circulating Tumor Cells (Devices or Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Circulating Tumor Cells (Devices or Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Circulating Tumor Cells (Blood) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Circulating Tumor Cells (Blood) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Circulating Tumor Cells (Bone Marrow) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Circulating Tumor Cells (Bone Marrow) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Circulating Tumor Cells (Other Body Fluids) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Circulating Tumor Cells (Other Body Fluids) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Circulating Tumor Cells (Hospital and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Circulating Tumor Cells (Hospital and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Circulating Tumor Cells (Research and Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Circulating Tumor Cells (Research and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Global: Circulating Tumor Cells (Diagnostic Centres) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Global: Circulating Tumor Cells (Diagnostic Centres) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: North America: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: North America: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: United States: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: United States: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Canada: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Canada: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Asia-Pacific: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Asia-Pacific: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: China: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: China: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Japan: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Japan: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: India: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: India: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: South Korea: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: South Korea: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Australia: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Australia: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Indonesia: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Indonesia: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Others: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Europe: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Europe: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Germany: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Germany: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: France: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: France: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: United Kingdom: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: United Kingdom: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Italy: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Italy: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Spain: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Spain: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Russia: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Russia: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Latin America: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Latin America: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Brazil: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Brazil: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Mexico: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Mexico: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Others: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Others: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Middle East and Africa: Circulating Tumor Cells Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 85: Middle East and Africa: Circulating Tumor Cells Market: Breakup by Country (in %), 2024
  • Figure 86: Middle East and Africa: Circulating Tumor Cells Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Global: Circulating Tumor Cells Industry: SWOT Analysis
  • Figure 88: Global: Circulating Tumor Cells Industry: Value Chain Analysis
  • Figure 89: Global: Circulating Tumor Cells Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Circulating Tumor Cells Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Circulating Tumor Cells Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 3: Global: Circulating Tumor Cells Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Circulating Tumor Cells Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 5: Global: Circulating Tumor Cells Market Forecast: Breakup by Specimen (in Million USD), 2025-2033
  • Table 6: Global: Circulating Tumor Cells Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Circulating Tumor Cells Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Circulating Tumor Cells Market: Competitive Structure
  • Table 9: Global: Circulating Tumor Cells Market: Key Players